These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20605773)

  • 1. Successful treatment of type 1 pityriasis rubra pilaris with ustekinumab therapy.
    Ruiz Villaverde R; Sánchez Cano D
    Eur J Dermatol; 2010; 20(5):630-1. PubMed ID: 20605773
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of pityriasis rubra pilaris with ustekinumab.
    Wohlrab J; Kreft B
    Br J Dermatol; 2010 Sep; 163(3):655-6. PubMed ID: 20491761
    [No Abstract]   [Full Text] [Related]  

  • 3. Pityriasis rubra pilaris successfully treated with infliximab.
    Ruiz-Genao DP; Lopez-Estebaranz JL; Naz-Villalba E; Gamo-Villegas R; Calzado-Villarreal L; Pinedo-Moraleda F
    Acta Derm Venereol; 2007; 87(6):552-3. PubMed ID: 17989902
    [No Abstract]   [Full Text] [Related]  

  • 4. Should ustekinumab really be used as first-line biological therapy in pityriasis rubra pilaris?
    Balestri R; Bardazzi F; Antonucci A
    Br J Dermatol; 2010 Oct; 163(4):896-7; author reply 897-8. PubMed ID: 20662839
    [No Abstract]   [Full Text] [Related]  

  • 5. Secukinumab emerges as a rapidly effective therapy for pityriasis rubra pilaris.
    Bonomo L; Levitt JO
    Cutis; 2018 May; 101(5):367-369. PubMed ID: 29894526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab.
    Ruzzetti M; Saraceno R; Carboni I; Papoutsaki M; Chimenti S
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):117-8. PubMed ID: 18181990
    [No Abstract]   [Full Text] [Related]  

  • 7. Pityriasis rubra pilaris responding rapidly to adalimumab.
    Walling HW; Swick BL
    Arch Dermatol; 2009 Jan; 145(1):99-101. PubMed ID: 19153364
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient.
    Gómez M; Ruelas ME; Welsh O; Arcaute HD; Ocampo-Candiani J
    J Drugs Dermatol; 2007 Mar; 6(3):337-9. PubMed ID: 17373198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrodermic pityriasis rubra pilaris managed at home: intensive community care followed by ustekinumab.
    Ismail N; Callander J; Williams M; Anstey AV
    Clin Exp Dermatol; 2018 Aug; 43(6):749-751. PubMed ID: 29779249
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term infliximab treatment for refractory type III juvenile pityriasis rubra pilaris.
    Dessinioti C; Vergou T; Moustou E; Katsambas A; Antoniou C
    Eur J Dermatol; 2011; 21(4):599-600. PubMed ID: 21518691
    [No Abstract]   [Full Text] [Related]  

  • 11. Pityriasis rubra pilaris.
    White KL
    Dermatol Online J; 2003 Oct; 9(4):6. PubMed ID: 14594579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risankizumab for pityriasis rubra pilaris.
    Brocco E; Laffitte E
    Clin Exp Dermatol; 2021 Oct; 46(7):1322-1324. PubMed ID: 33914925
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment with infliximab despite positive tuberculosis ELISpot results in a patient with pityriasis rubra pilaris taking prophylactic isoniazid.
    Zirbs M; Kigitsidou E; Seifert F; Ring J; Brockow K
    Clin Exp Dermatol; 2011 Oct; 36(7):808-9. PubMed ID: 21507042
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab.
    Manoharan S; White S; Gumparthy K
    Australas J Dermatol; 2006 May; 47(2):124-9. PubMed ID: 16637810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pityriasis rubra pilaris, type 1.
    Booth AV; Ma L
    Dermatol Online J; 2005 Dec; 11(4):9. PubMed ID: 16403381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series.
    Garcovich S; Di Giampetruzzi AR; Antonelli G; Garcovich A; Didona B
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):881-4. PubMed ID: 20002243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab for the treatment of adult-onset pityriasis rubra pilaris.
    Liao WC; Mutasim DF
    Arch Dermatol; 2005 Apr; 141(4):423-5. PubMed ID: 15837858
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of pityriasis rubra pilaris (type 1) under combination of infliximab and methotrexate.
    Barth D; Harth W; Treudler R; Simon JC
    J Dtsch Dermatol Ges; 2009 Dec; 7(12):1071-4. PubMed ID: 19689446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I pityriasis rubra pilaris treated with tumor necrosis factor inhibitors, ustekinumab, or secukinumab: A review.
    Maloney NJ; Hisaw LD; Worswick S
    J Am Acad Dermatol; 2018 Sep; 79(3):585-587. PubMed ID: 29518460
    [No Abstract]   [Full Text] [Related]  

  • 20. Pityriasis rubra pilaris triggered by photodynamic therapy with response to tumor necrosis factor α-blocking agents and acitretin.
    López-Ferrer A; Dalmau J; Fernández-Figueras MT; Puig L
    Cutis; 2014 Mar; 93(3):E6-7. PubMed ID: 24738108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.